40 results on '"Hevia, Vital"'
Search Results
2. CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY
3. Psychological Impact of Living Kidney Donation: A Systematic Review by the EAU—YAU Kidney Transplant Working Group
4. Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients
5. Effectiveness of endourological management of ureteral stenosis in kidney transplant patients: EAU-YAU kidney transplantation working group collaboration
6. Kidney Transplant Outcomes in Elderly Population: A Systematic Review and Meta-analysis
7. PD31-03 EFFECTIVENESS OF ENDOUROLOGICAL MANAGEMENT OF URETERAL STENOSIS IN KIDNEY TRANSPLANT PATIENTS: EAU-YAU KIDNEY TRANSPLANTATION WORKING GROUP COLLABORATION
8. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
9. Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney
10. Urologists and Kidney Transplantation: The First European Census
11. Endovesical Bacillus Calmette-Guérin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
12. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
13. Prostate Rhabdomyosarcoma presenting as acute urinary retention in a young adult
14. Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients
15. PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY
16. Corrigendum to ‘Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)’ [European Urology Oncology 3 (2021) 256–263]
17. Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
18. What Should Be Known by a Urologist About the Medical Management of COVID-19’s Patients?
19. Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
20. MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE
21. Does presence of bone metastases portend worsened prognosis in metastatic renal cell carcinoma? Analysis of the REMARCC (Registry of MetAstatic RCC) database.
22. Troubleshooting Complex Vascular Cases in the Kidney Graft: Multiple Vessels, Aneurysms, and Injuries During Harvesting Procedures
23. Troubleshooting Complex Vascular Cases in the Kidney Transplant Recipient: Vascular Anomalies, Challenging Vessel Diseases, and Procedural Disasters
24. Minimmally invasive resolution of a left ureteral stenosis after Schistosoma haematobium infection
25. Effectiveness and Harms of Using Kidneys with Small Renal Tumors from Deceased or Living Donors as a Source of Renal Transplantation: A Systematic Review
26. MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY
27. MicroRNAs in Kidney Hipothermic Machine Perfusion Fluid as Novel Biomarkers for Graft Function. Have Changes in Normalization Guidelines Support Previous Results?
28. Perfusion parameters during Hypothermic Machine Perfusion in Expanded Criteria Donors (ECD) and Donors after Circulatory Death (DCD). Does comparison allow their categorization?
29. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel
30. European Association of Urology Guidelines on Renal Transplantation: Update 2018
31. Serum Retinol, Folic Acid, and Copper Are Associated With Sperm Abnormalities in Men With Obesity
32. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review
33. Kidney autotransplantation: long-term outcomes and complications. Experience in a tertiary hospital and literature review
34. MP06-20 RANDOMIZED EXPERIMENTAL STUDY COMPARING NON-OXYGENATED VS OXYGENATED HYPOTHERMIC MACHINE PERFUSION IN A TYPE III NON-HEART-BEATING DONOR PIG MODEL OF AUTOTRANSPLANTATION.
35. MP06-17 UROTHELIAL CARCINOMA AFTER KIDNEY TRANSPLANT: A HETEROGENEUS ENTITY IN TERMS OF DIAGNOSIS, TREATMENTS AND ONCOLOGICAL OUTCOMES
36. Renal Complex Cystic Masses: Usefulness of Contrast-Enhanced Ultrasound (CEUS) in Their Assessment and Its Agreement with Computed Tomography
37. Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: tips, tricks and oncological results
38. Contrast-Enhanced Ultrasound (CEUS): an Excellent Tool in the Follow-up of Small Renal Masses Treated with Cryoablation
39. Orthotopic Kidney Transplant: a Valid Surgical Alternative for Complex Patients
40. Transitional Cell Carcinoma of the Kidney Graft: An Extremely Uncommon Presentation of Tumor in Renal Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.